Schizophrenia laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Schizophrenia}}
{{Schizophrenia}}
{{CMG}};{{AE}}{{Vbe}}
{{CMG}};{{AE}}{{Vbe}} {{I.D.}}


==Overview==
==Overview==


An initial assessment includes a comprehensive [[History and Physical examination|history]] and [[Physical culture|physical]] [[examination]] by a [[physician]]. Although there are no [[biological]] tests which confirm [[schizophrenia]], tests are carried out to exclude [[medical]] illnesses which may rarely present with [[psychotic]] [[schizophrenia]]-like [[symptoms]]. These include [[blood]] tests measuring [[Thyroid-stimulating hormone|TSH]] to exclude [[hypothyroidism|hypo-]] or [[hyperthyroidism]], [[Blood tests#Blood chemistry tests|basic electrolytes]] and serum [[calcium]] to rule out a [[metabolic]] disturbance, [[Complete blood count|full blood count]] including [[Erythrocyte sedimentation rate|ESR]] to rule out a systemic [[infection]] or [[Chronic (medical)|chronic]] [[disease]], and [[serology]] to exclude [[syphilis]] or [[HIV]] infection. Drugs of [[abuse]] should also be tested for with a urine [[drug]] [[Screening (medicine)|screen]], and further [[Diagnostic criteria|diagnostic]] workup is detailed [[Schizophrenia diagnostic studies|here]].
An initial assessment includes a comprehensive [[History and Physical examination|history]] and [[Physical culture|physical]] [[examination]] by a [[physician]]. Although there are no [[biological]] tests which confirm [[schizophrenia]], tests are carried out to exclude [[medical]] illnesses which may rarely present with [[psychotic]] [[schizophrenia]]-like [[symptoms]]. These include [[blood]] tests measuring [[Thyroid-stimulating hormone|TSH]] to exclude [[hypothyroidism|hypo-]] or [[hyperthyroidism]], [[Blood tests#Blood chemistry tests|basic electrolytes]] and serum [[calcium]] to rule out a [[metabolic]] disturbance, [[Complete blood count|full blood count]] including [[Erythrocyte sedimentation rate|ESR]] to rule out a systemic [[infection]] or [[Chronic (medical)|chronic]] [[disease]], and [[serology]] to exclude [[syphilis]] or [[HIV]] infection. Drugs of [[abuse]] should also be tested for with a urine [[drug]] [[Screening (medicine)|screen]], and further [[Diagnostic criteria|diagnostic]] workup is detailed [[Schizophrenia diagnostic studies|here]].<ref name="pmid20464730">{{cite journal| author=Gorczynski P, Faulkner G| title=Exercise therapy for schizophrenia. | journal=Cochrane Database Syst Rev | year= 2010 | volume=  | issue= 5 | pages= CD004412 | pmid=20464730 | doi=10.1002/14651858.CD004412.pub2 | pmc=4164954 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20464730  }} </ref>




==Laboratory Findings==
==Laboratory Findings==
An [[Initial-stress-derived noun|initial]] assessment includes a comprehensive [[History and Physical examination|history]] and [[Physical culture|physical]] [[Physical examination|examination]] by a physician. Although there are no [[biological]] tests which confirm [[schizophrenia]], tests are carried out to exclude medical illnesses which may rarely present with psychotic schizophrenia-like symptoms. These include blood tests measuring [[Thyroid-stimulating hormone|TSH]] to exclude [[hypothyroidism|hypo-]] or [[hyperthyroidism]], [[Blood tests#Blood chemistry tests|basic electrolytes]] and serum [[calcium]] to rule out a metabolic disturbance, [[Complete blood count|full blood count]] including [[Erythrocyte sedimentation rate|ESR]] to rule out a systemic infection or chronic disease, and [[serology]] to exclude [[syphilis]] or [[HIV]] infection. [[Drugs]] of [[abuse]] should also be tested for with a urine drug screen, and further [[diagnostic]] workup is detailed [[Schzophrenia diagnostic studies|here]].
*An [[Initial-stress-derived noun|initial]] assessment includes a comprehensive [[History and Physical examination|history]] and [[Physical culture|physical]] [[Physical examination|examination]] by a physician.<ref name="pmid26289586">{{cite journal| author=Dougall N, Maayan N, Soares-Weiser K, McDermott LM, McIntosh A| title=Transcranial magnetic stimulation (TMS) for schizophrenia. | journal=Cochrane Database Syst Rev | year= 2015 | volume=  | issue= 8 | pages= CD006081 | pmid=26289586 | doi=10.1002/14651858.CD006081.pub2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26289586  }} </ref>
*Although there are no [[biological]] tests which confirm [[schizophrenia]], tests are carried out to exclude medical illnesses which may rarely present with psychotic schizophrenia-like symptoms.<ref name="pmid18291627">{{cite journal| author=Tandon R, Keshavan MS, Nasrallah HA| title=Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. | journal=Schizophr Res | year= 2008 | volume= 100 | issue= 1-3 | pages= 4-19 | pmid=18291627 | doi=10.1016/j.schres.2008.01.022 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18291627  }} </ref>
**These include blood tests measuring [[Thyroid-stimulating hormone|TSH]] to exclude [[hypothyroidism|hypo-]] or [[hyperthyroidism]], [[Blood tests#Blood chemistry tests|basic electrolytes]] and serum [[calcium]] to rule out a metabolic disturbance, [[Complete blood count|full blood count]] including [[Erythrocyte sedimentation rate|ESR]] to rule out a systemic infection or chronic disease, and [[serology]] to exclude [[syphilis]] or [[HIV]] infection.
**[[Drugs]] of [[abuse]] should also be tested for with a urine drug screen, and further [[diagnostic]] workup is detailed [[Schzophrenia diagnostic studies|here]].


Investigations are not generally repeated for relapse unless there is a specific ''[[medical]]'' indication. These may include [[serum]] [[blood]] [[sugar]] level if [[olanzapine]] has previously been prescribed, [[liver]] function tests if [[chlorpromazine]] or [[CPK]] to exclude [[neuroleptic malignant syndrome]]. Assessment and [[Treatment-resistant depression|treatment]] are usually done on an [[outpatient]] basis; admission to an [[inpatient]] facility is considered if there is a [[Risk-benefit analysis|risk]] to self or others.
*Investigations are not generally repeated for relapse unless there is a specific ''[[medical]]'' indication.<ref name="pmid22560607">{{cite journal| author=Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G et al.| title=Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. | journal=Lancet | year= 2012 | volume= 379 | issue= 9831 | pages= 2063-71 | pmid=22560607 | doi=10.1016/S0140-6736(12)60239-6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22560607  }}  [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=&cmd=prlinks&id=22904562 Review in: Evid Based Ment Health. 2012 Nov;15(4):92] </ref>
*These may include [[serum]] [[blood]] [[sugar]] level if [[olanzapine]] has previously been prescribed, [[liver]] function tests if [[chlorpromazine]] or [[CPK]] to exclude [[neuroleptic malignant syndrome]].  
*Assessment and [[Treatment-resistant depression|treatment]] are usually done on an [[outpatient]] basis; admission to an [[inpatient]] facility is considered if there is a [[Risk-benefit analysis|risk]] to self or others.


==References==
==References==

Revision as of 17:12, 15 August 2018

Schizophrenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Schizophrenia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Social Impact

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Schizophrenia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Schizophrenia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Schizophrenia laboratory findings

CDC on Schizophrenia laboratory findings

Schizophrenia laboratory findings in the news

Blogs on Schizophrenia laboratory findings

Directions to Hospitals Treating Schizophrenia

Risk calculators and risk factors for Schizophrenia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2] Irfan Dotani

Overview

An initial assessment includes a comprehensive history and physical examination by a physician. Although there are no biological tests which confirm schizophrenia, tests are carried out to exclude medical illnesses which may rarely present with psychotic schizophrenia-like symptoms. These include blood tests measuring TSH to exclude hypo- or hyperthyroidism, basic electrolytes and serum calcium to rule out a metabolic disturbance, full blood count including ESR to rule out a systemic infection or chronic disease, and serology to exclude syphilis or HIV infection. Drugs of abuse should also be tested for with a urine drug screen, and further diagnostic workup is detailed here.[1]


Laboratory Findings

References

  1. Gorczynski P, Faulkner G (2010). "Exercise therapy for schizophrenia". Cochrane Database Syst Rev (5): CD004412. doi:10.1002/14651858.CD004412.pub2. PMC 4164954. PMID 20464730.
  2. Dougall N, Maayan N, Soares-Weiser K, McDermott LM, McIntosh A (2015). "Transcranial magnetic stimulation (TMS) for schizophrenia". Cochrane Database Syst Rev (8): CD006081. doi:10.1002/14651858.CD006081.pub2. PMID 26289586.
  3. Tandon R, Keshavan MS, Nasrallah HA (2008). "Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview". Schizophr Res. 100 (1–3): 4–19. doi:10.1016/j.schres.2008.01.022. PMID 18291627.
  4. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G; et al. (2012). "Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis". Lancet. 379 (9831): 2063–71. doi:10.1016/S0140-6736(12)60239-6. PMID 22560607. Review in: Evid Based Ment Health. 2012 Nov;15(4):92

Template:WH Template:WS